Pharmacys Prescription 4.5 OZ Cocoa Butter Petroleum Jelly

Manufacturer
American Consumer Products Corp
Effective date
2019-09-16
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:00:27

Label at a glance#

ProductPharmacys Prescription 4.5 OZ Cocoa Butter Petroleum Jelly
Active ingredientPETROLATUM
Label structure10 sections

Dosage and administration

Directions apply as needed.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active ingredient:

Petrolatum 30%

Purpose

OTC - PURPOSE SECTION

Purpose:

Skin Protectant

Uses:

Temporarily protects minor cuts, scrapes burns

Temporarily protects and helps relieve chapped or cracked skin

Helps protect from the drying effects of wind and cold weather

Warnings

WARNINGS SECTION

Warnings

For external use only

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: Water (aqua), Mineral Oil, Glycerin, Cetearyl Alcohol, Cetyl Alcohol, Stearyl Alcohol, Glyceryl Stearate, Fragrance, Polysorbate 80, Laureth-20, BHT, Methylparaben, Propylparaben, Dimethicone, Theobroma Cacao (Cocoa) Seed Butter, Tocopheryl Acetate.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions apply as needed.

INSTRUCTIONS FOR USE SECTION

Do not use on deep puncture wounds, animal bites, serious burns.

Stop use and ask a doctor

OTC - STOP USE SECTION

Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days.

Indications & Usage

INDICATIONS & USAGE SECTION

When using this product do not get into eyes.

Pharmarcys Prescription 4.5 OZ Creamy Cocoa Butter Petroleum Jelly

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Pharmacys Prescription Creamy Cocoa Butter Petroleum JellyPharmacys Prescription Creamy Cocoa Butter Petroleum Jelly

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1037285petrolatum 30 % Topical GelPSN2
1037285petrolatum 0.3 MG/MG Topical GelSCD2
1037285petrolatum 30 % Topical GelSY2
1037285petrolatum 30 % Topical JellySY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72197-014-042023-01-30C16284748780-1f386c649-a104-0266-e053-dadaa90a7c1aPharmacys Prescription 4.5 OZ Cocoa Butter Petroleum Jelly

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72197-014-04Pharmacys Prescription 4.5 OZ Cocoa Butter Petroleum Jelly127.57 g in 1 TUBEJELLY127.572

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72197-014PHARMACYS PRESCRIPTION 4.5 OZ COCOA BUTTER PETROLEUM JELLY (WHITE PETROLATUM) JELLY [AMERICAN CONSUMER PRODUCTS CORP]2Legacy NDC, 1 package rows20190917_9133e376-c9ec-c528-e053-2a95a90aabe5.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72197-01472197-014-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
91c311b2-a230-0db0-e053-2995a90af3ef9133e376-c9ec-c528-e053-2a95a90aabe52019-09-16WarningsExact identifier
spl id: 91c311b2-a230-0db0-e053-2995a90af3ef
spl set id: 9133e376-c9ec-c528-e053-2a95a90aabe5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.